There are 3163 resources available
319TiP - NeoBREASTIM: A phase II study of atezolizumab plus RP1 oncolytic immunotherapy in the neoadjuvant setting of triple-negative breast cancer (TNBC)
Presenter: Etienne Bastien
Session: Poster session 14
321P - Sentinel lymph node biopsy in clinical T3-4c breast cancer: A retrospective multicenter cohort study
Presenter: Yasuaki Sagara
Session: Poster session 14
322P - Incidence patterns for locally advanced operable breast cancer by receptor status: SEER 2010-2021
Presenter: Alexandra Thomas
Session: Poster session 14
323P - SPEN: Unraveling breast cancer's genetic symphony — Prognostic significance and therapeutic insights
Presenter: Sameer Emeish
Session: Poster session 14
324P - Application of advanced machine learning techniques to improve prognosis in primary breast angiosarcoma
Presenter: Haya Kamal
Session: Poster session 14
Resources:
Abstract
325P - The clinical validity of histological grade in neoadjuvant treated breast cancer
Presenter: Sanna Steen
Session: Poster session 14
326P - Exploratory analysis of the association of systemic inflammation and breast cancer recurrence in the Optitrain randomised controlled trial
Presenter: Marlene Rietz
Session: Poster session 14
327P - Monitoring over time of pathological complete response to neoadjuvant chemotherapy in breast cancer patients through an ensemble vision transformers-based model
Presenter: Maria Colomba Comes
Session: Poster session 14
328P - Real-world evidence (RWE) of effectiveness and safety of TCHP regimen: INSIGHT-HER2BC trial interim results
Presenter: Daur Meretukov
Session: Poster session 14
329P - RANK/RANKL, ERBB-2: A putative dual targeting strategy in RANK+/Her2+ breast carcinomas patients
Presenter: Michalis Karamouzis
Session: Poster session 14